Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | -0.03 |   |
Earnings Per Share | -$0.0031 |   |
Price To Sales Ratio | 8.20 |   |
Price To Book Ratio | N/A | |
Price To Tangible Book Ratio | N/A | |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 20.4M |   |
Float (MRQ) | N/A | |
Shares Outstanding (MRQ) | 102.1M |   |
Short Interest as a % of Float (MRQ) | N/A | |
Shares Held By Institutions (MRQ) | N/A |
Margins | Industry Range | |
---|---|---|
Sales | $1.1M |   |
Gross Margin | 20.76% |   |
Net Profit Margin | -29.11% |   |
EBIT Margin | -8.76% |   |
EBITDA Margin | -8.76% |   |
Operating Margins | -8.76% |   |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 0.62 |   |
Quick Ratio (MRQ) | 0.62 |   |
Total Debt/Equity Ratio (MRQ) | N/A | |
Debt/Common Equity Ratio (MRQ) | N/A |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | 10.35% |   |
Return on Assets | -8.93% |   |
Asset Turnover | 0.31 |   |
Receivables Turnover | 0.31 |   |
Inventory Turnover | 529.90 |   |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | N/A | |
Dividend Yield 5 Year Average | 0.00% | |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | 0.00 |
*CGRW does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Other industry is N/A